Skip to navigation
Skip to content
Skip to footer
CDx
Careers
ENG
English
Français
中文
Clinical Trial Services
Clinical Trial Services
Early Phase
Late Phase
CDx Development
Regulatory Services
Sample Logistics
AI & Data Analytics
Quality Management System
CAP, CLIA & ISO Accreditations
IVDR
Biorepository
Biospecimen Procurement
Clinical Kitting
Clinical Site Training
PBMC Processing
Sample Management
Bioinformatics & Biostatistics
Genomic Data Analysis
CellEngine® Cytometry Software
Capabilities
Biomarker Capabilities
Genomics
Histopathology
Immune Monitoring
Immunoassays
Proteomics
Sequencing Services
Assays by Mutations
Digital PCR (dPCR)
Quantitative PCR (qPCR)
Genomic Data Analysis
Liquid Biopsy Platform
Spatial Biology
Digital Pathology
IHC Services
ISH
Pathology Team
Spatial Biology
Basophil Activation Test (BAT)
Cell Enumeration
Cell Phenotyping
Cell Proliferation
Fluorescence-Activated Cell Sorting (FACS)
Intracellular Cytokine Staining (ICS)
Receptor Occupancy (RO)
ELISA
Ella™ Multiplexing ELISA
FluoroSpot & ELISpot
Hybrid LBA/LC-MS
MSD® Meso Scale Discovery
Olink™ PEA Technology
Unbiased Discovery
Biomarker Quantification
Next-Generation Sequencing (NGS)
RNA Sequencing (RNAseq)
Single Cell Sequencing
Therapeutic Areas
Therapeutic Areas
Therapeutic Modalities
Autoimmune
Immunology
Infectious Diseases
Neurosciences
Oncology
Antibody-Drug Conjugates
Cell Therapy
Targeted Protein Degraders
Platforms
Platforms
Flow Cytometry
Immunoassays
Mass Cytometry (CyTOF)
Mass Spectrometry
Sequencing Platform
Staining & Imaging
ELISA
Ella™ Multiplexing ELISA
FluoroSpot & ELISpot
Hybrid LBA/LC-MS
MSD® Meso Scale Discovery
Olink™ PEA Technology
Science Hub
Science Hub
Blog
Brochures
Case Studies
Posters
Videos
Publications
Webinars
About
About
Our Story
Our Team
Our Global Network
News
Events
Contact Us
Clinical Trial Services
Biomarker Capabilities
Therapeutic Areas
Platforms
Science Hub
About
Contact Us
CDx
Back
Early Phase
Late Phase
CDx Development
Regulatory Services
Sample Logistics
AI & Data Analytics
Back
Regulatory Services
Quality Management System
CAP, CLIA & ISO Accreditations
IVDR
Back
Sample Logistics
Biorepository
Biospecimen Procurement
Clinical Kitting
Clinical Site Training
PBMC Processing
Sample Management
Back
AI & Data Analytics
Bioinformatics & Biostatistics
Genomic Data Analysis
CellEngine® Cytometry Software
Back
Genomics
Histopathology
Immune Monitoring
Immunoassays
Proteomics
Back
Genomics
Sequencing Services
Assays by Mutations
Digital PCR (dPCR)
Quantitative PCR (qPCR)
Genomic Data Analysis
Liquid Biopsy Platform
Spatial Biology
Back
Sequencing Services
Next-Generation Sequencing (NGS)
RNA Sequencing (RNAseq)
Single Cell Sequencing
Back
Histopathology
Digital Pathology
IHC Services
ISH
Pathology Team
Spatial Biology
Back
Immune Monitoring
Basophil Activation Test (BAT)
Cell Enumeration
Cell Phenotyping
Cell Proliferation
Fluorescence-Activated Cell Sorting (FACS)
Intracellular Cytokine Staining (ICS)
Receptor Occupancy (RO)
Back
Immunoassays
ELISA
Ella™ Multiplexing ELISA
FluoroSpot & ELISpot
Hybrid LBA/LC-MS
MSD® Meso Scale Discovery
Olink™ PEA Technology
Back
Proteomics
Unbiased Discovery
Biomarker Quantification
Back
Therapeutic Modalities
Autoimmune
Immunology
Infectious Diseases
Neurosciences
Oncology
Back
Therapeutic Modalities
Antibody-Drug Conjugates
Cell Therapy
Targeted Protein Degraders
Back
Flow Cytometry
Immunoassays
Mass Cytometry (CyTOF)
Mass Spectrometry
Sequencing Platform
Staining & Imaging
Back
Immunoassays
ELISA
Ella™ Multiplexing ELISA
FluoroSpot & ELISpot
Hybrid LBA/LC-MS
MSD® Meso Scale Discovery
Olink™ PEA Technology
Back
Blog
Brochures
Case Studies
Posters
Videos
Publications
Webinars
Back
Our Story
Our Team
Our Global Network
News
Events
Close AI assistant
CellCarta AI assistant
Hi, I'm the CellCarta AI Assistant. Ask me anything about our services.
Home
Biomarkers US 2026
Biomarkers US 2026
Jul 21, 2026
Featured Resources
See All Experts' Insights
Aug 6, 2026
CellCarta Adds Tempus to CDx Commercialization Lab Network
Jul 15, 2026
CellCarta Launches Global Digital Pathology & AI Consortium
Jun 23, 2026
CellCarta and Pillar Biosciences Accelerate FGFR NGS Assay from RUO to IUO for Global Phase 3 Oncology Trial | CellCarta
See All Experts' Insights
×
